Lonza · 11 hours ago
Core Technician– Cell Therapy
Houston, TX
Part-time
Onsite
New Grad, Entry LevelLonza is a global leader in life sciences manufacturing, and they are seeking a Core Technician for their Cell Therapy team. The role involves participating in the aseptic processing of clinical grade products and maintaining the cleanroom environment.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Stocks cleanroom suites and supports areas with released inventory
Supports cleanroom environment maintenance at below alert limits by following established cleaning practice
Orders supplies through RenCS
Packages kits, blood tubes and final product for shipment
Monitors expiry of critical raw materials as needed
A majority of the work is done in cleanroom environment
Qualification
Required
Responsible for carrying out production processes in a GMP facility, with tasks including cell culture
Basic Lab experience with a bachelor's degree or Intermediate Lab experience within a cGMP clinical production environment and a High School Diploma
Ability to read, understand and follow production schedule
Ability to perform aseptic manipulations without causing product contamination
Ability to read, understand and follow SOP's
Perform aseptic gowning on a daily basis, and ability to stand for up to 6 hours
Ability to routinely lift up to 50 lbs
Benefits
Performance-related bonus.
Medical, dental and vision insurance.
401(k) matching plan.
Life insurance, as well as short-term and long-term disability insurance.
Employee assistance programs.
Paid time off (PTO).
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Founded in 1897
10001+ employees
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Leadership Team
Wolfgang Wienand
Chief Executive Officer
Alfons Ehinger
Founder
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase